PhRMA welcomes Genentech and Gilead Sciences to association

January 17, 2019 by Chain Drug Review Bill Anderson, biopharmaceutical companies, Genentech, Gilead, Pharmaceutical Research and Manufacturers of America (PhRMA), Stephen Ubl Leading Headlines, Pharmacy

WASHINGTON – Pharmaceutical Research and Manufacturers of America (PhRMA) announced today that Genentech, a member of the Roche Group, South San Francisco, and Gilead Sciences, Inc., Foster City, Calif. joined the association as members. Genentech and Gilead Sciences are two of the world’s leading biopharmaceutical companies dedicated to discovering and developing medicines to fundamentally change how patients with life-threatening